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Abstract:
Continuous Performance Tests (CPT) have proven effective for monitoring the effects of treatments for ADHD, especially 
neurofeedback and virtual reality. The Integrated Visual and Auditory Continuous Performance Test (IVA/CPT), which is ba-
sed on the DSM-IV diagnostic criteria, allows hyperactive-impulsive symptoms and inattention to be assessed at the visual and 
auditory level. The goal of this study is to determine whether the IVA/CPT is a useful scale to measure the therapeutic efficacy 
of neurofeedback. A total of 16 male and female subjects ages 7-14 with a diagnosis of ADHD who had been randomly assigned 
to neurofeedback treatment participated in the study. Attention and hyperactivity were the variables evaluated in the pre- and 
post-treatment phases. Through comparisons of means and effect size calculation, the efficacy of neurofeedback was estimated 
according to the children’s performance in the auditory and visual variables of the CPT/IVA. The data obtained reveal signifi-
cant improvement in self-control and symptoms of inattention following the treatment. 
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Introduction
Continuous Performance Tests (CPT), currently consid-
ered an alternative to paper and pencil tests, allow sustained 
attention and behavioral inhibition to be measured while 
allowing for the objective monitoring of therapeutic effects. 
They have proven effective for monitoring the change asso-
ciated with treatments administered in ADHD (Madaan et 
al., 2008; Monastra, 2002; Epstein, 2001), especially neuro-
feedback (Arns, de Ridder, Strehl, Breteler y Coenen, 2009; 
Moreno et al., 2011) and virtual reality (Yan et al., 2008).
The Integrated Visual and Auditory Continuous Perfor-
mance Test (IVA/CPT) (Sandford and Turner, 1995) which 
is based on the DSM-IV diagnostic criteria, allows hyperac-
tive-impulsive symptoms and inattention to be evaluated at 
the visual and auditory level. It is administered from the age 
of 6 through adulthood and it takes 20 minutes. It has been 
used to evaluate attention and self-control problems (White, 
Hutchens and Lubar, 2005; Corbett and Constantin, 2006) 
and as an objective scale for measuring therapeutic effects. 
In ADHD treatment, the IVA/CPT has been used to com-
pare the effects of pharmacological therapy with respect to 
modifications in behavioral patterns (Harding, Judah and 
Gant, 2003) and in relation to neurofeedback (Yan et al., 
2008; Moreno et al., 2011), with significant differences de-
tected on the principal scales (inattention and behavior con-
trol). Smith and Sams (2005) obtained significant changes 
in relation to inattentive symptoms in a group of adolescents 
with disruptive behaviors who were treated with neurofeed-
back. At the same time, when measuring therapeutic effica-
cy in a multimodal treatment (neurofeedback and cognitive 
therapy), Tinius and Tinius (2000) noted significant differ-
ences in inattention and behavioral inhibition among adults 
with ADHD (inattentive subtype) and a control group. 
Objectives
To determine whether the IVA is a useful scale to measure 
the therapeutic efficacy of neurofeedback, a treatment ad-
ministered to children diagnosed with ADHD.
Method
A total of 16 male and female subjects ages 7-14 with a di-
agnosis of ADHD who had been randomly assigned to neu-
rofeedback treatment participated in the study. The minors 
were evaluated using the CPT/IVA . 
Results
Attention and hyperactivity are the two variables evaluated 
in the pre- and post-treatment phases. Through comparisons 
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of means and effect size calculation, the efficacy of neuro-
feedback was estimated according to the children’s perfor-
mance in the auditory and visual variables (respectively) of 
the CPT/IVA. The data obtained in the study reveal signifi-
cant improvement in self-control (FRCQ t= -2.509; p<0.05) 
and with respect to symptoms of inattention (VAQ t=-2.910; 
p<0.05) following the treatment. The results taken from the 
TE show values of between 1.03 and 0.69 and 0.80 and 0.57 
for self-control and symptoms of inattention.
Discussion and conclusions
CPT/IVA was confirmed as a useful scale to measure the 
therapeutic efficacy of neurofeedback. Medium and high 
effect sizes reflect the magnitude of the change between 
pre-treatment and post-treatment measurements.
The changes were observed in terms of both self-control and 
symptoms of inattention. The therapeutic effects can be seen 
independently of the type of stimulus presented (auditory or 
visual), although the data reflect that the change is greater 
when children are responding to visual stimuli.
References
Arns, M., de Ridder, S., Strehl, U., Breteler, M. y Coenen, A. 
(2009) Efficacy of neurofeedback treatment in ADHD: 
the effects on inattention, impulsivity and hyperactivity: a 
meta-analysis. Clinical EEG and Neurosciences, 40(3), 180 
-189.
Corbett, B. A. y Constantine, L. J. (2006). Autism and at-
tention deficit hyperactivity disorder: assessing attention 
and response control with the integrated visual and audi-
tory continuous performance test. Child Neuropsychology 
12(4–5), 335 – 348.
Harding, K., Judah, R. D. y Gant, C. E. (2003). Out-
come-based comparison of Ritalin versus Food-supple-
ment treated children with AD/HD. Alternative Medicine 
Review, 8(3), 319 – 330.
Madaan, V., Daughton, J., Lubberstedt, B., Mattai, A., 
Vaughan, B.S. y Kratochvil, C.J. (2008). Assessing the effi-
cacy of treatments for ADHD: Overview of methodologi-
cal issues. CNS Drugs, 22(4), 275-290.
Moreno, I., Lora, J. A., Aires, M. M. y Meneres, S. (2011). 
Tratamiento de neurofeedback en el trastorno por déficit 
de atención e hiperactividad. Efectos registrados a partir 
de medidas neurológicas. En R. Quevedo-Blasco y V. J. 
Quevedo-Blasco (Comps.) Situación Actual de la Psicología 
Clínica. (pp.31-34) Granada: Asociación Española de Psi-
cología Conductual.
Sandford, J. A., y Turner, A. (1995). Integrated visual and au-
ditory continuous performance test manual. Richmond, VA: 
Brain Train.
Smith, P. N. y Sams, M. W. (2005). Neurofeedback with Juve-
nile Offenders: A Pilot Study in the Use of QEEG-Based 
and Analog-Based Remedial Neurofeedback Training. 
Journal of Neurotherapy,9(3), 87-99.
Tinius, T. P. y Tinius, K. A. (2000). Changes after EEG bi-
ofeedback and cognitive retraining in adults with mild 
traumatic brain injury and attention deficit hyperactivity 
disorder.Journal of neurotherapy, 4(2), 27 - 43.
White, J. N., Hutchens, T. A. y Lubar, J. F. (2005). Quanti-
tative EEG assessment during neuropsychological task 
performance in adults with attention deficit hyperactivity 
disorder.Journal of Adult Development, 12, 113 – 121.
Yan, N., Wang, J., Liu, M., Zong, L., Jiao, Y., Yue, J., Lv, Y., 
Yang, Q., Lan, H. y Liu, Z. (2008). Designing a Brain-com-
puter Interface Device for Neurofeedback Using Virtual 
Environments. Journal of Medical and Biological Engineer-
ing, 28(3), 167-172.
Acknowledgements
Project funded by the national R+D+i plan (PSI2008-
06008-C02-01) (Spanish Ministry of Science and Innovation). 
